Literature DB >> 24694572

Necrotizing fasciitis: The need for urgent surgical intervention and the impact of intravenous drug use.

Carmel Waldron1, Jacqueline Gemma Solon2, Joanne O'Gorman3, Hilary Humphreys3, John Patrick Burke1, Deborah Ann McNamara1.   

Abstract

BACKGROUND: Necrotizing fasciitis (NF) is a relatively rare infection of soft tissues. This study reviewed the epidemiology and pathophysiology of admissions to a tertiary referral hospital over a twelve year period comparing outcomes and findings with international norms and to identify potential areas of change to optimise outcomes. STUDY
DESIGN: A retrospective review of patients diagnosed with NF from Jan 1st 1999 to Dec 31st 2011 was performed. Patient demographics, risk factors, operative procedures, microbiology results and outcomes were recorded. Comparative analysis was performed.
RESULTS: 37 patients were admitted with NF, comprising 30 males and 7 females with a median age of 55 years. The most common site of infection was the perineum (51%). The overall mortality rate was 29% and was significantly associated with age greater than 60 years (p = 0.0018) and the presence of one or more risk factor (p = 0.0046). The number of surgical procedures ranged from one to fifteen with a median length of stay of 35.5 days. There was a significant increase in the number of admissions in 2009-2010 (p < 0.001), coinciding with the emergence of NF in intravenous drug users (IVDU). 43% of patients (n = 16/37) required skin grafting, which was significantly higher in the IVDU group (n = 5/6, p = 0.0232).
CONCLUSIONS: Necrotizing fasciitis remains a significant life-threatening event. The diversity of causative pathogens emphasises the need for prompt microbiology/infectious diseases consultation. The increased occurrence within the IVDU cohort in this study highlights the need for a heightened level of clinical suspicion in these patients to prompt early surgical intervention.
Copyright © 2014 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Intravenous drug users; Necrotizing fasciitis; Outcomes

Mesh:

Year:  2014        PMID: 24694572     DOI: 10.1016/j.surge.2014.01.005

Source DB:  PubMed          Journal:  Surgeon        ISSN: 1479-666X            Impact factor:   2.392


  5 in total

Review 1.  Necrotising fasciitis in the COVID-19 era: A consequence of caution - A case series.

Authors:  Gerard Feeney; Enda Hannan; John Fallon; Eimear Curran; Helen Meagher; Jean Sheehan; John Calvin Coffey; Eamon G Kavanagh
Journal:  Int J Surg Open       Date:  2022-05-11

2.  Improvement of a Clinical Score for Necrotizing Fasciitis: 'Pain Out of Proportion' and High CRP Levels Aid the Diagnosis.

Authors:  Thomas Borschitz; Svenja Schlicht; Ekkehard Siegel; Eric Hanke; Esther von Stebut
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

3.  Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs.

Authors:  Pedro Luis Gonzalez; Urania Rappo; Karthik Akinapelli; Jennifer S McGregor; Sailaja Puttagunta; Michael W Dunne
Journal:  Drugs Context       Date:  2018-12-11

4.  Necrotizing Fasciitis Due to Prevotella denticola Infection in an Intravenous Drug User.

Authors:  Jeremiah Ling; Takashi Hirase
Journal:  Cureus       Date:  2022-01-03

5.  What's new in emergencies, trauma and shock? The tortuous path in the management of necrotizing fasciitis: Is early surgical intervention critical?

Authors:  Debabrata Bandyopadhyay; Jordan V Jacobs; Tanmay S Panchabhai
Journal:  J Emerg Trauma Shock       Date:  2016 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.